Company Filing History:
Years Active: 2009
Title: Innovations in Eye and Ear Therapy by Ulrich Schraermeyer
Introduction
Ulrich Schraermeyer is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of medical therapies, particularly focusing on diseases affecting the eye, inner ear, and central nervous system. His innovative work has led to the development of novel medicaments that address conditions induced by oxidative stress.
Latest Patents
Ulrich Schraermeyer holds 1 patent related to his research. The patent is titled "Therapy of diseases of the eye, the inner ear and the central nervous system." This invention involves the use of 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole-2-carboxylic acid (DHICA), and/or 5-S-cysteinyldopa (CD) as medicaments. It also explores the use of tyrosinase for preparing a medicament aimed at the prophylaxis or therapy of diseases caused by oxidative stress. Additionally, the patent discusses gene therapy vectors that incorporate a tyrosinase gene and cells modified by this gene.
Career Highlights
Ulrich Schraermeyer is associated with Cevec Pharmaceuticals GmbH, where he continues to advance his research and development efforts. His work at this company emphasizes the importance of innovative therapies in treating complex medical conditions.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Ulrich Schraermeyer's contributions to medical innovation, particularly in therapies for eye and ear diseases, highlight the potential of his research to improve patient outcomes. His patent reflects a significant step forward in addressing conditions related to oxidative stress.